Marketresearchnews

Sunday, 20 September 2020

Spinal Traction Market is Growing Massively till 2023

Market Synopsis

According to a new report by Market Research Future (MRFR), the global spinal traction devices market is expected to reach USD 6.0 billion by the end of 2023. The market is envisaged to witness a steady growth to expand at 7.7 % CAGR over the forecast period (2017-2023) owing to the growing geriatric population. Spinal traction devices are used to stabilize and decompress the spine for treating several spinal disorders and orthopedic conditions like bone fractures, muscle contracture, and bone deformities like kyphosis, scoliosis, and lordosis. These devices are also used in treating low back pain and muscle spasms. Spinal traction devices are also used to prepare patients for surgical procedures like interbody fixation, endoscopic spine surgery, vertebral compression fracture repair, and interspinous fixation.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1902

Future Drivers and Constraints

Increasing production number of spinal surgery, implants, and ongoing researches for improving the quality of care are expected to create attractive growth opportunities for the market globally. With the increasing cases of trauma and spinal cord diseases, growing geriatric population, increase in the number of spinal surgeries, screening and awareness, and developing healthcare are some of the factors propelling the market growth over the review period.

Also, the shift in the preference among patients and surgeons for adopting minimally invasive (MI) surgery over traditional surgeries have resulted in the development of advanced spinal implants. The rising number of clinical trials of latest technology implants is also propelling the market growth over the assessment period.

Innovation has remained the best strategy with companies focusing on developing new devices which can offer better treatment and diagnostic to various types of spine conditions. Wireless sensor technology is one of the latest researches with advanced products connected to external devices for analysis and healing progress.

Meanwhile, costly devices, lack of experimental clinical data in medical treatment, risk related after surgery which comprises risk of damage and infection to the spine, and demand for minimally invasive procedures is assessed to hamper the growth of the market over the forecast period.

Global Spinal Traction Market Segmentation

The global market for spinal traction has been segmented on the basis of diagnosis, type, treatment, end-users, and region.

The market has been segmented into mechanical spinal traction and manual spinal traction based on types. The market has been segmented into herniated discs, sciatica, facet disease, slipped discs, bone spurs, foraminal stenosis, pinched nerves, and degenerative disc disease, based on applications. The market has been segmented into gravity-dependent traction, manual traction, and continuous traction based on devices.

The market has also been segmented into academic and research, hospitals and clinics, and others based on end-users. Among these, the segment for hospital dominated the global market for spinal traction and is predicted to maintain its dominance over the assessment period.

Regional Analysis

Geographically, the market for spinal traction has been spanned across regions such as North America, the Middle East and Africa, Europe, and Asia Pacific.

The North American region is anticipated to hold the largest market share due to the high expenditure on healthcare. Also, adoption of medical devices and new diagnostics in the U.S. is also expected to drive the market in this region. Moreover, the presence of large hospital networks and major healthcare companies in the developed countries is propelling the market growth over the assessment period.

Europe holds the second largest position after North America, owing to the penetration of strong healthcare and high income in this region. Countries such as France and Germany are expected to lead the market growth in the European region. The UK is anticipated to emerge as the fastest growing market over the review period due to the presence of strong pharmaceutical industry.

Asia Pacific is estimated to grow rapidly over the assessment period. India and China are likely to lead the market owing to the huge unmet requirement and fast-growing healthcare sector over the assessment period. Moreover, South East Asian countries like India, China, and Malaysia are estimated to contribute to the market growth. Also, increasing penetration of healthcare insurance in the Asia Pacific region is anticipated to spur the market growth in this region.

Moreover, the UAE and Saudi Arabia are anticipated to drive the Middle East and African market. The African region is expected to witness moderate growth due to poor political and economic conditions.

Industry News

Natural compounds derived from Australian plants have been found to stimulate cells and are useful for transplantation to repair injuries in the spinal cord. The results have been published in the Scientific Reports by a team of scientists recently at the Menzies Health Institute Queensland and Griffith Institute for Drug Discovery.

Competition Analysis

The prominent players operating the spinal traction market are Stoll Medizintechnik GmbH, Spinal Designs International Inc., Saunders Group Inc., SpineRx Technology, VAX-D Medical Technologies LLC., Scrip, Inc. BTL, North American Medical (NAM) Corporation, Spinetronics, LLC, Dentsply International, Medtronic Inc., CERT Health Sciences LLC, Hill Laboratories Company, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/spinal-traction-market-1902

HIFU Treatment Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

Market Highlights

High-intensity focused ultrasound (HIFU) therapy is a novel, emerging, and therapeutic modality technology. It involves propagation of ultrasound waves through cancerous tissues that kills cancer cells. HIFU is a minimal invasive technique and is performed with real-time imaging by ultrasound or MRI to enable treatment targeting and monitoring. This technology have been extensively exploited for the treatment of prostate, liver, pancreatic, and bladder cancer. The American Cancer Society estimated that about 161,360 new cases of prostate cancer have been registered in the US in 2017. Moreover, the number of people living beyond a cancer diagnosis were nearly 14.5 million in 2014 and is expected to rise to over 19 million by 2024. Moreover, increasing development in the medical technology and its wide range of application used in the treatment of uterine fibroids, neurological disorders, cosmetic medicine and others fuel the growth of this market. However, high cost of the treatment and certain adverse effects are likely to restrain the market growth over the forecasted period.

The global HIFU treatment market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/885

Major Players in High intensity focused ultrasound (HIFU) therapy Market

Some of the key players in the global market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.

Regional Analysis

The global high intensity focused ultrasound (HIFU) therapy market consists of four regions including the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global HIFU therapy market. North America is the largest market owing to rising prevalence of cancer cases in the American counties and well-developed technology in this region contributes majorly to the growth of this market.

Europe accounts for the second largest share of the global HIFU therapy market. In the Europe, wide demand for cancer diseases treatment methods drives the market growth. Moreover, increasing expenditure in the healthcare domain and investment in research & development in developing new treatment methods for cancer diseases will fuel to the growth of this market.

Asia Pacific is the fastest growing market in the world. India is the largest potential market due to increasing investments in healthcare services and increasing adaption of new technologies used for diagnosis and treatment methods.

The Middle East & Africa is expected to witness a steady growth due to rising demand for primary healthcare services such as new and advanced treatment methods in healthcare domain.

Segmentation

The global high intensity focused ultrasound (HIFU) therapy market has been segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others. On the basis of the methods, the market is segmented into non-invasive method and minimal invasive method. On the basis of applications, the market has been segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others. On the basis of end users, the market has been segmented into diagnostic centers, hospitals, research centers, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/high-intensity-focused-ultrasound-therapy-market-885

Global Tularemia Market Research Report 2020 Analysis and Forecast to 2023

Market scenario

Tularemia or rabbit fever or deer fly fever is a rare infectious disease caused by the bacterium Francisella tularensis, which affects skin, eyes, lymph nodes and lungs. Tularemia is transmitted from animals such as rodents, rabbits, and hares to human. It can also affect sheep, birds, dogs, cats, etc. The routes of acquiring infection are direct exposure to the bacteria, airborne infections, insect bites, and bite of an infected animal. Tularemia is highly contagious and had been used as a biological weapon by many countries such as United States of America and Soviet Union. Ulceroglandular tularemia is the most common form of Tularemia. Tularemia symptoms include swollen and painful lymph glands, fever, chills, headache, fatigue, eye swelling, pain and light sensitivity, diarrhea, pneumonia etc. If it left untreated, it will cause serious complications such as enlarged spleen, enlarged liver, infection around the brain and spinal cord, irritation around the heart (pericarditis), bone infection etc. and may lead to the death.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4120

Factors favouring the spread of Tularemia infection are tick bites, exposure to sick or dead animals, especially, wild game. Travel to certain regions such as Arkansas, Missouri and Oklahoma can also cause Tularemia infection because of the concentration of ticks in those areas. Tick bite is the leading cause for an occurrence of large number of cases.Laboratory workers working with tularemia are at risk of airborne infection due to greater chances of exposure to the pathogen. Tularemia infection can also be airborne during gardening, construction or other activities, which may lead to pneumonic tularemia. Tularemia is also contracted by eating undercooked meat of an infected animal or drinking contaminated water. According to Centers for Disease Control and Prevention, overall mortality of Tularemia is less than 2% but ranges up to 24% depending on the strain.

The global Tularemia treatment market is expected to reach US$ 200 million by 2023, and the market is projected to grow at a CAGR of ~ 3.2 % during the forecast period 2017-2023.

Sources: U.S. Department of Health and Human Services National Institutes of Health, Centers for Disease Control and Prevention, Mayo Clinic, MRFR Analysis

Intended Audience

Global Tularemia manufacturers & suppliers
Research and development (R&D) companies
Hospitals and clinics
Academic institutes and universities

Segments

The global Tularemia market has been segmented on the basis of types, diagnosis, drugs, and end users.

Based on types, the market has been segmented as the ulceroglandular tularemia, glandular tularemia, oculoglandular tularemia, oropharyngeal tularemia, pneumonic tularemia, and others.

Based on the diagnosis, the market has been segmented as microscopy, immunochemistry, and others.

Based on the drugs, the market has been segmented as streptomycin, gentamicin, doxycycline, ciprofloxacin and others.

Based on the end users, the market has been segmented as hospitals and clinics, academic and research centers, and others.

Regional analysis

The Americas accounts for the significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global Tularemia market. However the presence and concentration of Tularemia in the US regions, for instance, Arkansas, Missouri, Dakota, Oklahoma, etc. are the leading cause for the dominance of US in the global Tularemia market. Europe is the second largest market in the globe due to a high disposable income and rising awareness about the disease.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead the market due to unmet needs during the forecast period.

Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. However Africa is also a region of high endemic and untreated cases of Tularemia.

Key Players in the Global Tularemia Market

Some of key players profiled in the report are Nicholas Piramal, Alkem, Glaxo Smithkline, Bayer AG, Ranbaxy Laboratories, Cipla Inc., Zydus Cadila, Dr. Reddy's Lab, Glenmark Pharmaceuticals, Lupin Limited, pfizer Inc. and others.

The report for Global Tularemia market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/tularemia-market-4120

Ovulation Test kit Market to Witness Widespread Expansion During 2020 to 2023

Market Highlights

The global HIFU treatment market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/885

Major Players in High intensity focused ultrasound (HIFU) therapy Market

Regional Analysis

The global high intensity focused ultrasound (HIFU) therapy market consists of four regions including the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Middle East & Africa is expected to witness a steady growth due to rising demand for primary healthcare services such as new and advanced treatment methods in healthcare domain.

Segmentation

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/high-intensity-focused-ultrasound-therapy-market-885

Thursday, 17 September 2020

Global Skin Graft Market Growth Factors, Types And Application By Regional Analysis 2023

Market Highlights

The skin graft market share is chiefly driven by rise in cases of accidents, burns, surgeries requiring removal of skin, skin loss due to infection such as necrotizing fasciitis or purpura fulminans and cancer etc. The rise in the number of plastic surgeries due to the growing influence of the fashion and media industry coupled with the development of tourism sector has led to the growth of the market. The global skin graft market represents a bipolar outlook with huge difference in the rural and metropolitan regions. The developed metropolitan regions especially with tourism and fashion industry sectors such as Bangkok, Las Vegas, and Los Angeles etc. have skin graft surgeries disproportionate to their population and needs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1674

The skin graft market is led by the product development strategy which is being witnessed in the equipment section and most prominently the dermatome. Dermatome is a surgical instrument used to create thin slice the skin in skin grafting. Latest technological developments have led to the development of advanced dermatomes such as air dermatome which is more efficient and allows for greater control and accuracy in slicing skin of uniform thickness. As the use of dermatomes is dependent on the skill of the surgeons, scarcity of skilled surgeons is acting as a constraint on the global skin graft market.

Global Skin graft Market Players:
Key players profiled in the report are Organogenesis, Inc., Specmed Medical, Stratatech Corp, Tissue Regenix Group PLC, Avita Medical, Convatec Inc, Medrotonic, Coloplast, B.Braun Melsungen, zimmerbiomet, Stratatech Corporation, Zimmer Biomet and others.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Skin graft Market” Research Report – Forecast to 2023.

Segmentation:
The global skin graft market is segmented on the basis of graft type, graft thickness and applications. Based on graft type, the market has been segmented as autologous, isogeneic, allogeneic, xenogeneic and prosthetic. Based on the graft thickness, the market has been segmented as split-thickness, full-thickness and composite graft. Based on the applications, the market has been segmented as extensive wound, burns, extensive skin loss due to infection, skin cancers and others. Based on the equipment, the market has been segmented as dermatome (knives dermatomes, drum dermatomes, electric dermatomes, air dermatomes), general surgical instruments, consumables and others. Based on the end users, the market has been segmented as hospitals and clinics, academic and research and others.

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/skin-graft-market-1674

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

MEA HIV Diagnosis & Treatment Market Expects An Extensive Growth In Roi Till 2023

Market Scenario:

HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV. Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2990

Middle East and Africa HIV AIDS Diagnosis & Treatment Market is growing moderately. Middle East and Africa HIV Diagnosis & Treatment Market is expected to grow at a CAGR of 3.3% and expected to reach US$ 2.07 billion by 2023 from US$ 1.65 billion in 2016.

Study objectives of Middle East and Africa HIV Diagnosis & Treatment Market:

To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa HIV Diagnosis & Treatment Market
To provide insights about factors affecting the market growth in this region
To analyze the Middle East and Africa HIV Diagnosis & Treatment Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries
To provide detailed analysis of the market with respect to the current market size and future prospective
To provide detailed analysis of the market for segments by diagnosis, by treatment, and its sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle East and Africa HIV Diagnosis & Treatment Market.

Key Players for Middle East and Africa HIV Diagnosis & Treatment Market:

Some of the key players in this market are: Abbott Laboratories (US), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (US), Cipla Inc. (India), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc.(US), ViiV Healthcare group of companies (UK), Merck & Co., Inc. (US).

Segments:

Middle East and Africa HIV Diagnosis & Treatment Market has been segmented on the basis of diagnosis which comprise ELISA Test, Saliva Tests, Viral Load Test, Western Blot, and Others. On the basis of treatment, market is segmented into Protease inhibitors (PIs), Non-nucleoside reverse transcriptase inhibitors (NNRTIs), Nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs), Entry or fusion inhibitors, Integrase inhibitors, and others.

Regional Analysis of Middle East and Africa HIV Diagnosis & Treatment Market:

Considering the scenario of the Middle East and African HIV Diagnosis & Treatment market, Africa is believed to be the largest market for HIV Diagnosis & Treatment. Moreover, the Rest of Middle East and Africa is growing and it is the second largest market for Middle East and Africa HIV Diagnosis & Treatment. On the other hand, UAE market is expected to grow at significant rate in the Middle East and Africa HIV Diagnosis & Treatment during the forecasted period. Saudi Arabia is likely to have a limited but moderate growth in the market.

The report for Middle East and Africa HIV Diagnosis & Treatment Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/hiv-diagnosis-treatment-market-2990

World Veterinary Software Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2027

Market Highlights

Global Veterinary Software Market share is expected to register a CAGR of 7.46% during the forecast period, with a market value of USD 804.94 Million by 2027.

Veterinary software is a system, which is used by veterinarians to manage the veterinary practice. The software is developed to improve the performance of veterinary practice through the easily accessed and well-organized computerized system. Diagnostic software gives access to lab technicians. Vets have all the information they need for monitoring the health of pigs or poultry. Inventory management software is used in hospitals & clinics to track the inventory, including sales tracking, stock level management, purchase order creation/tracking, and tracking margins, among others. The rise in companion animal ownership, growing prevalence of animal diseases, and rise in pet insurance with increasing animal health expenditure are expected to drive the growth of the global veterinary software market. However, lack of government encouragements for software acceptance and unwillingness to adopt the latest technologies are expected to hamper the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3156

Segment Analysis

Global Veterinary Software Market has been segmented by Software Type, Deployment, Data Type, and End User.

The Global Veterinary Software Market, by Software Type, has been segmented into practice management software, diagnostic software, inventory management software, and others. The global veterinary software market, by deployment, has been segmented into on-premise and cloud based. The global veterinary software market, by data type, has been segmented into patient EMR (Pets), medical supplies & stock data, customer data, and others. The global veterinary software market, by end-user, has been segmented into veterinary hospitals & clinics, research laboratories, educational institutes, and others.

Regional Analysis

Global Veterinary Software Market, on the basis of region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas accounted for the largest share in the Global Veterinary Software Market. The largest share is majorly attributed to the increased adoption of practice management software, rise in veterinary healthcare expenditure, increasing demand for pet insurance, and growing pet ownership. According to the report published by the American Pet Products Association, from 2017 to 2018, 68% of the US households or 85 million families have a pet. Europe is the second-largest market for veterinary software owing to the presence of large market players, innovative advanced technologies, increasing companion animal ownerships, and the presence of veterinaries.

The Asia-Pacific region is the third-largest market owing to the presence of large animal population, growing disposal income, increasing nuclear families preferring to have pets and rise in investments by the American and European market players in countries such as China and India. Moreover, the accepted and established pet food industry is fueling the growth of the veterinary software market in this region. The market in the Middle East & Africa is constrained due to the poor development of the animal industry and the low productivity of most of the breeds in the region.

Key Findings of the Study

The Global Veterinary Software Market was valued at USD 21 Million in 2019 and is expected to register a CAGR of 7.46% during the assessment period of 2019 to 2027
The Americas accounted for the largest share of the global veterinary software market
Based on the software type, the practice management software segment is expected to register the highest CAGR of 7.95% during the forecast period
Based on deployment, the cloud-based segment is expected to register the highest CAGR of 8.53% during the forecast period
Based on data type, the patient EMR segment accounted for a larger market share in 2019
Based on end user, the veterinary hospitals & clinics segment accounted for a larger market share of 59.76% in 2019

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/veterinary-software-market-3156